ATS 2018 International Conference - Mobile

The Matrix-Fibroblast Interplay: Nintedanib and Pirfenidone Modulate the Effect of IPF Fibroblast Conditioned Matrix on Normal Fibroblast Phenotype [Board No. P639]

Location: Board no. P639

Session Type: Thematic Poster Session

Sunday

May

20

11:15 AM

1:00 PM

Speaker(s)/Author(s)

David Shitrit

MD
Meir medical center

Lutz Wollin

PhD
Boehringer Ingelheim Pharma GmbH & Co. KG

Gali Epstein Shochet

PhD
Meir Medical Center

View Abstract

The Matrix-Fibroblast Interplay: Nintedanib and Pirfenidone Modulate the Effect of IPF Fibroblast Conditioned Matrix on Normal Fibroblast Phenotype

Parent Sessions

A68 - MOLECULAR DETERMINANTS OF REMODELING IN LUNG FIBROSIS...
05-20-2018 9:15 AM - 4:15 PM